Global Drug based on CAR T-Cell Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2210030027 | Category: Pharma & Healthcare | Pages: 111 | Format: PDF | Published Date: October 27,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer.
According to our (Global Info Research) latest study, the global Drug based on CAR T-Cell market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Drug based on CAR T-Cell market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2022, are provided.
Key Features:
Global Drug based on CAR T-Cell market size and forecasts, in consumption value ($ Million), 2017-2028
Global Drug based on CAR T-Cell market size and forecasts by region and country, in consumption value ($ Million), 2017-2028
Global Drug based on CAR T-Cell market size and forecasts, by Type and by Application, in consumption value ($ Million), 2017-2028
Global Drug based on CAR T-Cell market shares of main players, in revenue ($ Million), 2017-2022
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Drug based on CAR T-Cell
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Drug based on CAR T-Cell market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J and JW Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Drug based on CAR T-Cell market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    CD19-targeted
    BCMA-targeted
Market segment by Application
    Lymphoma
    Multiple Myeloma
Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite
    CARsgen Therapeutics (Pipeline)
    CARsgen Therapeutics
    Autolus Therapeutics
    Sorrento Therapeutics
    Mustang Bio
    Bluebird Bio
    Cellectis
    Allogene Therapeutics
    Celyad
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drug based on CAR T-Cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drug based on CAR T-Cell, with revenue, gross margin and global market share of Drug based on CAR T-Cell from 2017 to 2022.
Chapter 3, the Drug based on CAR T-Cell competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Drug based on CAR T-Cell market forecast, by regions, type and application, with consumption value, from 2023 to 2028.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug based on CAR T-Cell.
Chapter 13, to describe Drug based on CAR T-Cell research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Drug based on CAR T-Cell
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Drug based on CAR T-Cell by Type
        1.3.1 Overview: Global Drug based on CAR T-Cell Market Size by Type: 2017 Versus 2021 Versus 2028
        1.3.2 Global Drug based on CAR T-Cell Consumption Value Market Share by Type in 2021
        1.3.3 CD19-targeted
        1.3.4 BCMA-targeted
    1.4 Global Drug based on CAR T-Cell Market by Application
        1.4.1 Overview: Global Drug based on CAR T-Cell Market Size by Application: 2017 Versus 2021 Versus 2028
        1.4.2 Lymphoma
        1.4.3 Multiple Myeloma
    1.5 Global Drug based on CAR T-Cell Market Size & Forecast
    1.6 Global Drug based on CAR T-Cell Market Size and Forecast by Region
        1.6.1 Global Drug based on CAR T-Cell Market Size by Region: 2017 VS 2021 VS 2028
        1.6.2 Global Drug based on CAR T-Cell Market Size by Region, (2017-2028)
        1.6.3 North America Drug based on CAR T-Cell Market Size and Prospect (2017-2028)
        1.6.4 Europe Drug based on CAR T-Cell Market Size and Prospect (2017-2028)
        1.6.5 Asia-Pacific Drug based on CAR T-Cell Market Size and Prospect (2017-2028)
        1.6.6 South America Drug based on CAR T-Cell Market Size and Prospect (2017-2028)
        1.6.7 Middle East and Africa Drug based on CAR T-Cell Market Size and Prospect (2017-2028)
2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Drug based on CAR T-Cell Product and Solutions
        2.1.4 Novartis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Drug based on CAR T-Cell Product and Solutions
        2.2.4 Gilead Sciences Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.2.5 Gilead Sciences Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Product and Solutions
        2.3.4 Bristol-Myers Squibb Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 J & J
        2.4.1 J & J Details
        2.4.2 J & J Major Business
        2.4.3 J & J Drug based on CAR T-Cell Product and Solutions
        2.4.4 J & J Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.4.5 J & J Recent Developments and Future Plans
    2.5 JW Therapeutics
        2.5.1 JW Therapeutics Details
        2.5.2 JW Therapeutics Major Business
        2.5.3 JW Therapeutics Drug based on CAR T-Cell Product and Solutions
        2.5.4 JW Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.5.5 JW Therapeutics Recent Developments and Future Plans
    2.6 FOSUNKite
        2.6.1 FOSUNKite Details
        2.6.2 FOSUNKite Major Business
        2.6.3 FOSUNKite Drug based on CAR T-Cell Product and Solutions
        2.6.4 FOSUNKite Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.6.5 FOSUNKite Recent Developments and Future Plans
    2.7 CARsgen Therapeutics (Pipeline)
        2.7.1 CARsgen Therapeutics (Pipeline) Details
        2.7.2 CARsgen Therapeutics (Pipeline) Major Business
        2.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product and Solutions
        2.7.4 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.7.5 CARsgen Therapeutics (Pipeline) Recent Developments and Future Plans
    2.8 CARsgen Therapeutics
        2.8.1 CARsgen Therapeutics Details
        2.8.2 CARsgen Therapeutics Major Business
        2.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Product and Solutions
        2.8.4 CARsgen Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.8.5 CARsgen Therapeutics Recent Developments and Future Plans
    2.9 Autolus Therapeutics
        2.9.1 Autolus Therapeutics Details
        2.9.2 Autolus Therapeutics Major Business
        2.9.3 Autolus Therapeutics Drug based on CAR T-Cell Product and Solutions
        2.9.4 Autolus Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.9.5 Autolus Therapeutics Recent Developments and Future Plans
    2.10 Sorrento Therapeutics 
        2.10.1 Sorrento Therapeutics Details
        2.10.2 Sorrento Therapeutics Major Business
        2.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Product and Solutions
        2.10.4 Sorrento Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.10.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.11 Mustang Bio
        2.11.1 Mustang Bio Details
        2.11.2 Mustang Bio Major Business
        2.11.3 Mustang Bio Drug based on CAR T-Cell Product and Solutions
        2.11.4 Mustang Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.11.5 Mustang Bio Recent Developments and Future Plans
    2.12 Bluebird Bio
        2.12.1 Bluebird Bio Details
        2.12.2 Bluebird Bio Major Business
        2.12.3 Bluebird Bio Drug based on CAR T-Cell Product and Solutions
        2.12.4 Bluebird Bio Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.12.5 Bluebird Bio Recent Developments and Future Plans
    2.13 Cellectis
        2.13.1 Cellectis Details
        2.13.2 Cellectis Major Business
        2.13.3 Cellectis Drug based on CAR T-Cell Product and Solutions
        2.13.4 Cellectis Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.13.5 Cellectis Recent Developments and Future Plans
    2.14 Allogene Therapeutics
        2.14.1 Allogene Therapeutics Details
        2.14.2 Allogene Therapeutics Major Business
        2.14.3 Allogene Therapeutics Drug based on CAR T-Cell Product and Solutions
        2.14.4 Allogene Therapeutics Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.14.5 Allogene Therapeutics Recent Developments and Future Plans
    2.15 Celyad
        2.15.1 Celyad Details
        2.15.2 Celyad Major Business
        2.15.3 Celyad Drug based on CAR T-Cell Product and Solutions
        2.15.4 Celyad Drug based on CAR T-Cell Revenue, Gross Margin and Market Share (2017-2022)
        2.15.5 Celyad Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Drug based on CAR T-Cell Revenue and Share by Players (2017-2022)
    3.2 Market Share Analysis (2021)
        3.2.1 Market Share of Drug based on CAR T-Cell by Company Revenue
        3.2.2 Top 3 Drug based on CAR T-Cell Players Market Share in 2021
        3.2.3 Top 6 Drug based on CAR T-Cell Players Market Share in 2021
    3.3 Drug based on CAR T-Cell Market: Overall Company Footprint Analysis
        3.3.1 Drug based on CAR T-Cell Market: Region Footprint
        3.3.2 Drug based on CAR T-Cell Market: Company Product Type Footprint
        3.3.3 Drug based on CAR T-Cell Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
    4.1 Global Drug based on CAR T-Cell Consumption Value and Market Share by Type (2017-2022)
    4.2 Global Drug based on CAR T-Cell Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Drug based on CAR T-Cell Consumption Value Market Share by Application (2017-2022)
    5.2 Global Drug based on CAR T-Cell Market Forecast by Application (2023-2028)
6 North America
    6.1 North America Drug based on CAR T-Cell Consumption Value by Type (2017-2028)
    6.2 North America Drug based on CAR T-Cell Consumption Value by Application (2017-2028)
    6.3 North America Drug based on CAR T-Cell Market Size by Country
        6.3.1 North America Drug based on CAR T-Cell Consumption Value by Country (2017-2028)
        6.3.2 United States Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        6.3.3 Canada Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        6.3.4 Mexico Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
7 Europe
    7.1 Europe Drug based on CAR T-Cell Consumption Value by Type (2017-2028)
    7.2 Europe Drug based on CAR T-Cell Consumption Value by Application (2017-2028)
    7.3 Europe Drug based on CAR T-Cell Market Size by Country
        7.3.1 Europe Drug based on CAR T-Cell Consumption Value by Country (2017-2028)
        7.3.2 Germany Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        7.3.3 France Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        7.3.5 Russia Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        7.3.6 Italy Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
8 Asia-Pacific
    8.1 Asia-Pacific Drug based on CAR T-Cell Consumption Value by Type (2017-2028)
    8.2 Asia-Pacific Drug based on CAR T-Cell Consumption Value by Application (2017-2028)
    8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region
        8.3.1 Asia-Pacific Drug based on CAR T-Cell Consumption Value by Region (2017-2028)
        8.3.2 China Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        8.3.3 Japan Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        8.3.4 South Korea Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        8.3.5 India Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        8.3.7 Australia Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
9 South America
    9.1 South America Drug based on CAR T-Cell Consumption Value by Type (2017-2028)
    9.2 South America Drug based on CAR T-Cell Consumption Value by Application (2017-2028)
    9.3 South America Drug based on CAR T-Cell Market Size by Country
        9.3.1 South America Drug based on CAR T-Cell Consumption Value by Country (2017-2028)
        9.3.2 Brazil Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        9.3.3 Argentina Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
10 Middle East & Africa
    10.1 Middle East & Africa Drug based on CAR T-Cell Consumption Value by Type (2017-2028)
    10.2 Middle East & Africa Drug based on CAR T-Cell Consumption Value by Application (2017-2028)
    10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country
        10.3.1 Middle East & Africa Drug based on CAR T-Cell Consumption Value by Country (2017-2028)
        10.3.2 Turkey Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
        10.3.4 UAE Drug based on CAR T-Cell Market Size and Forecast (2017-2028)
11 Market Dynamics
    11.1 Drug based on CAR T-Cell Market Drivers
    11.2 Drug based on CAR T-Cell Market Restraints
    11.3 Drug based on CAR T-Cell Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War
12 Upstream and Industry Chain
    12.1 Raw Material of Drug based on CAR T-Cell and Key Suppliers
    12.2 Manufacturing Costs Percentage of Drug based on CAR T-Cell
    12.3 Drug based on CAR T-Cell Production Process
    12.4 Industry Value Chain Analysis
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Drug based on CAR T-Cell Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?